Pregnolia has raised 4 million Swiss francs following an oversubscribed financing round. There is still the possibility of raising additional capital of up to 1 million Swiss francs, the Schlieren-based start-up writes in a press release.
Pregnolia has developed a measuring device that is able to reliably detect the risks of premature births. For this, a probe is used to measure the stiffness of the cervix. If it is too soft, the doctor can initiate therapeutic measures in good time.
Last year, Pregnolia had already received a grant in the amount of 1.4 million Swiss francs from the Horizon 2020 program. This capital was used for the technical optimization of the system as well as to make improvements to the manufacturing process. Pregnolia’s development has already been authorized as a measuring device for the stiffness of the cervix. The funds raised from the most recent financing round are now set to primarily be used for preparations in connection with the market launch as a diagnosis device.